Organ-on-a-chip (OOC) technology aims to more accurately reproduce human physiology in vitro, addressing the limitations of current approaches. This field is advancing rapidly. Image Credit: CN Bio ...
For those considering adding Organ-on-a-chip (OOC) technology into the workflow, it may be unclear where to start. Firstly, using a commercially available solution, such as CN Bio's PhysioMimix ®, ...
The current drug discovery process is inefficient, with a significant number of drugs halting clinical trials, pending more investigational work to understand causality, or failing due to unforeseen ...
Optimizing drug delivery systems (DDS) for the biological environment of organs and blood vessels is crucial for maximizing the effectiveness of drug treatment. A research team, affiliated with UNIST ...
Recently the FDA scolded Americans interested in Ivermectin as a COVID-19 treatment by tweeting “You are not a horse. You are not a cow.” The FDA’s tendentious sarcasm is ironic given that the FDA ...
CN Bio, announced the establishment of a strategic partnership with Pharmaron. Under the agreement, Pharmaron will validate CN Bio’s PhysioMimix ® technology across existing applications and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results